🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for Junctional Epidermolysis Bullosa

A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez NCT06423573n/a12 sites📍 Palo Alto📍 Aurora📍 Gainesville Chiesi Farmaceutici S.p.A. · Tests: Filsuvez Gentamicin for Junctional Epidermolysis Bullosa NCT03526159Phase 1, Phase 21 site📍 Los Angeles University of Southern California · Tests: Gentamicin Sulfate A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study NCT06594393Phase 213 sites📍 Cincinnati📍 Paris📍 Athens Xinnate AB · Tests: TCP-25 gel, Vehicle (placebo) A Study to Evaluate ENERGI-F703EB Cream in Epidermolysis Bullosa NCT07858422Phase 21 site📍 Tainan Energenesis Biomedical Co., Ltd. · Tests: ENERGI-F703EB Cream, Matched vehicle cream A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa NCT06917690Phase 36 sites📍 Fukuoka📍 Fukuoka📍 Kobe Chiesi Farmaceutici S.p.A. · Tests: Oleogel-S10
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy